|
|
|
xv | |
|
|
|
xix | |
|
|
|
1 | (2) |
|
An approach to the oncology consultation |
|
|
2 | (1) |
|
1 Clinical approach to suspected cancer |
|
|
3 | (14) |
|
|
|
4 | (1) |
|
|
|
5 | (1) |
|
|
|
6 | (1) |
|
|
|
7 | (1) |
|
Upper gastrointestinal cancer |
|
|
8 | (1) |
|
Lower gastrointestinal cancer |
|
|
9 | (1) |
|
|
|
10 | (1) |
|
|
|
11 | (1) |
|
|
|
12 | (1) |
|
|
|
13 | (1) |
|
|
|
14 | (1) |
|
|
|
15 | (1) |
|
Skin cancer---non-melanoma |
|
|
16 | (1) |
|
3 Concepts of multidisciplinary management |
|
|
17 | (38) |
|
|
|
18 | (4) |
|
|
|
22 | (2) |
|
|
|
24 | (4) |
|
|
|
28 | (4) |
|
Principles of cancer diagnosis and management |
|
|
32 | (6) |
|
Principles of surgical oncology |
|
|
38 | (4) |
|
|
|
42 | (4) |
|
Principles of systemic therapy |
|
|
46 | (9) |
|
4 Site-specific cancer management |
|
|
55 | (512) |
|
|
|
|
Principles of management for cancer of the head and neck |
|
|
58 | (4) |
|
Tumours of the eye, orbit, and ear |
|
|
62 | (2) |
|
|
|
64 | (2) |
|
Nose, nasal cavity, and paranasal sinuses |
|
|
66 | (2) |
|
|
|
68 | (2) |
|
|
|
70 | (2) |
|
|
|
72 | (1) |
|
|
|
73 | (1) |
|
|
|
74 | (2) |
|
Uncommon tumours of head and neck |
|
|
76 | (2) |
|
|
|
78 | (4) |
|
|
|
|
Primary brain tumours: introduction |
|
|
82 | (2) |
|
Brain tumours: clinicopathology |
|
|
84 | (2) |
|
Brain tumours: presentation and general management |
|
|
86 | (2) |
|
Brain tumours: surgical management |
|
|
88 | (4) |
|
Brain tumours: radiotherapy |
|
|
92 | (4) |
|
Brain tumours: chemotherapy and new agents |
|
|
96 | (4) |
|
Outcome and management of recurrence |
|
|
100 | (4) |
|
Brain tumours: summary of management |
|
|
104 | (2) |
|
Brain metastases: introduction |
|
|
106 | (2) |
|
Brain metastases: treatment options for brain metastases |
|
|
108 | (3) |
|
Brain metastases: outcome and summary |
|
|
111 | (1) |
|
Spinal cord tumours: introduction |
|
|
112 | (2) |
|
Spinal cord tumours: management |
|
|
114 | (2) |
|
Spinal cord tumours: outcome |
|
|
116 | (2) |
|
|
|
|
|
|
118 | (1) |
|
Lung cancer: introduction, screening and smoking cessation |
|
|
119 | (1) |
|
Lung cancer: diagnosis and staging |
|
|
120 | (3) |
|
Lung cancer: pathology and therapeutic implications |
|
|
123 | (1) |
|
Treatment of stage I non-small-cell lung cancer |
|
|
124 | (4) |
|
Lung cancer: treatment of stages II and III non-small-cell lung cancer |
|
|
128 | (2) |
|
Chemotherapy in stage IV non-small-cell lung cancer |
|
|
130 | (4) |
|
|
|
134 | (2) |
|
|
|
136 | (2) |
|
|
|
138 | (4) |
|
|
|
142 | (3) |
|
|
|
145 | (1) |
|
Solitary fibrous tumour of the pleura |
|
|
146 | (2) |
|
|
|
|
Breast cancer: introduction |
|
|
148 | (2) |
|
Breast cancer: pathogenesis and pathology |
|
|
150 | (2) |
|
Breast cancer: clinical features, diagnosis, staging, and prognostic factors |
|
|
152 | (4) |
|
Breast cancer: management of carcinoma in situ |
|
|
156 | (2) |
|
Management of breast cancer: surgery |
|
|
158 | (2) |
|
Breast cancer role of adjuvant radiotherapy |
|
|
160 | (2) |
|
Early stage breast cancer: adjuvant systemic treatment |
|
|
162 | (4) |
|
Locally advanced breast cancer concepts in management |
|
|
166 | (2) |
|
Management of recurrent and metastatic breast cancer |
|
|
168 | (2) |
|
Breast cancer: new agents and future perspectives |
|
|
170 | (1) |
|
Triple-negative breast cancer |
|
|
171 | (1) |
|
|
|
172 | (1) |
|
|
|
173 | (1) |
|
|
|
174 | (2) |
|
Gastro-intestinal cancers |
|
|
|
Oesophageal cancer: epidemiology and clinical features |
|
|
176 | (2) |
|
Oesophageal cancer: screening, diagnosis, and staging |
|
|
178 | (2) |
|
Oesophageal cancer: treatment of localized disease |
|
|
180 | (2) |
|
Oesophageal cancer: treatment of advanced disease, symptom control, and palliation |
|
|
182 | (2) |
|
Gastric cancer: introduction and clinical features |
|
|
184 | (2) |
|
Gastric cancer: screening, diagnosis, staging and prognosis |
|
|
186 | (2) |
|
Gastric cancer: treatment of localized disease |
|
|
188 | (2) |
|
Gastric cancer: treatment of advanced disease, symptom control, and palliative care |
|
|
190 | (2) |
|
Hepatocellular cancer: introduction |
|
|
192 | (2) |
|
Hepatocellular cancer: clinical features and staging |
|
|
194 | (4) |
|
Hepatocellular cancer: management |
|
|
198 | (4) |
|
Biliary tract tumours: introduction |
|
|
202 | (2) |
|
Biliary tract tumours: clinical features, staging, and prognosis |
|
|
204 | (4) |
|
Biliary tract tumours: management |
|
|
208 | (4) |
|
Pancreatic cancer: introduction |
|
|
212 | (2) |
|
Pancreatic cancer: diagnosis, staging, and prognosis |
|
|
214 | (2) |
|
Pancreatic cancer: treatment of resectable cancer |
|
|
216 | (2) |
|
Pancreatic cancer: treatment of unresectable and metastatic cancer |
|
|
218 | (2) |
|
Uncommon pancreatic tumours |
|
|
220 | (2) |
|
Tumours of small intestine |
|
|
222 | (4) |
|
Colorectal cancer: introduction |
|
|
226 | (2) |
|
Colorectal cancer: genetics, screening, and prevention |
|
|
228 | (6) |
|
Colorectal cancer: clinical features, diagnosis, and staging |
|
|
234 | (4) |
|
Colorectal cancer: treatment of localized disease |
|
|
238 | (2) |
|
Colorectal cancer: adjuvant treatment |
|
|
240 | (4) |
|
Colorectal cancer: treatment of advanced colorectal cancer |
|
|
244 | (4) |
|
Colorectal cancer: prognosis, follow-up, and management of recurrence |
|
|
248 | (4) |
|
Anal cancer: introduction |
|
|
252 | (2) |
|
|
|
254 | (4) |
|
|
|
|
Cancer of kidney: introduction |
|
|
258 | (2) |
|
Cancer of kidney: prognosis and surgical management |
|
|
260 | (2) |
|
Cancer of kidney: non-surgical management |
|
|
262 | (2) |
|
Urothelial and bladder cancer: introduction |
|
|
264 | (2) |
|
Urothelial and bladder cancer: diagnosis, staging, and prognosis |
|
|
266 | (2) |
|
Bladder cancer: management of localized and muscle invasive disease |
|
|
268 | (4) |
|
Bladder cancer: management of advanced and metastatic disease |
|
|
272 | (2) |
|
Non-transitional urothelial cancer: management |
|
|
274 | (1) |
|
Prostate cancer: introduction |
|
|
275 | (1) |
|
Prostate cancer: clinical features, diagnosis, and staging |
|
|
276 | (2) |
|
Prostate cancer: natural history, screening, and prognosis |
|
|
278 | (2) |
|
Prostate cancer: treatment of localized disease |
|
|
280 | (4) |
|
Prostate cancer: treatment of advanced disease |
|
|
284 | (2) |
|
Prostate cancer: detection and treatment of recurrence |
|
|
286 | (2) |
|
Prostate cancer: palliative care and symptom control |
|
|
288 | (2) |
|
Testicular cancer: introduction |
|
|
290 | (2) |
|
Testicular cancer: clinical features, diagnosis, TIN, staging, and prognosis |
|
|
292 | (4) |
|
Testicular cancer: prognosis and management of advanced disease |
|
|
296 | (4) |
|
Testicular cancer: management of low stage seminoma |
|
|
300 | (2) |
|
Testicular cancer: management of low stage non-seminoma |
|
|
302 | (2) |
|
Testicular cancer: follow-up and rare testicular tumours |
|
|
304 | (2) |
|
Testicular cancer: fertility issues and survivorship |
|
|
306 | (2) |
|
Penile cancer: introduction |
|
|
308 | (2) |
|
Penile cancer: management |
|
|
310 | (2) |
|
Cancer of the ureter and renal pelvis |
|
|
312 | (2) |
|
|
|
|
Cervical cancer: epidemiology, screening, and pathology |
|
|
314 | (2) |
|
Cervical cancer: clinical features, investigations, staging, and prognosis |
|
|
316 | (2) |
|
Cervical cancer: primary management |
|
|
318 | (5) |
|
Cervical cancer: management of recurrence |
|
|
323 | (1) |
|
Cervical cancer: role of chemotherapy |
|
|
324 | (1) |
|
Cervical cancer: treatment-related morbidity |
|
|
325 | (1) |
|
Cervical cancer: newer approaches |
|
|
326 | (2) |
|
|
|
328 | (2) |
|
Endometrial cancer: diagnosis, screening, and pathology |
|
|
330 | (2) |
|
Endometrial cancer: investigations, staging, and prognosis |
|
|
332 | (2) |
|
Endometrial cancer: role of surgery |
|
|
334 | (2) |
|
Endometrial cancer: role of radiotherapy |
|
|
336 | (2) |
|
Endometrial cancer: role of chemotherapy and hormonal agents |
|
|
338 | (2) |
|
Endometrial cancer: recurrence and metastasis |
|
|
340 | (2) |
|
|
|
342 | (2) |
|
Uterine sarcomas: management |
|
|
344 | (2) |
|
Epithelial ovarian cancer: introduction, pathology, and clinical features |
|
|
346 | (2) |
|
Epithelial ovarian cancer: investigations, staging, and prognosis |
|
|
348 | (1) |
|
Epithelial ovarian cancer: early stage disease |
|
|
349 | (1) |
|
Epithelial ovarian cancer: advanced stage disease |
|
|
350 | (2) |
|
Epithelial ovarian cancer: recurrent disease |
|
|
352 | (2) |
|
Epithelial ovarian cancer: palliative care issues |
|
|
354 | (2) |
|
Malignant ovarian germ cell tumours: introduction |
|
|
356 | (2) |
|
Malignant ovarian germ cell tumours: management |
|
|
358 | (2) |
|
Malignant ovarian germ cell tumours: prognosis, surveillance, and management of recurrence |
|
|
360 | (2) |
|
|
|
362 | (6) |
|
Gestational trophoblastic disease |
|
|
368 | (2) |
|
Gestational trophoblastic disease: diagnosis, staging and prognosis |
|
|
370 | (2) |
|
Gestational trophoblastic disease: low risk |
|
|
372 | (2) |
|
Gestational trophoblastic disease: high risk |
|
|
374 | (2) |
|
Gestational trophoblastic disease: special situations |
|
|
376 | (2) |
|
Cancers of vulva and vagina |
|
|
378 | (4) |
|
Management of vulval cancer |
|
|
382 | (2) |
|
Management of vaginal cancer |
|
|
384 | (2) |
|
|
|
|
|
|
386 | (4) |
|
|
|
390 | (2) |
|
|
|
392 | (2) |
|
Malignant skin adnexal tumours |
|
|
394 | (2) |
|
Cutaneous melanoma: introduction, clinical features, and staging |
|
|
396 | (2) |
|
Cutaneous melanoma: management of non-metastatic disease |
|
|
398 | (2) |
|
Cutaneous melanoma: management of metastatic disease |
|
|
400 | (4) |
|
|
|
404 | (2) |
|
Bone tumours and soft tissue sarcomas |
|
|
|
Bone tumours: introduction |
|
|
406 | (2) |
|
Bone tumours: clinical features, diagnosis, and staging |
|
|
408 | (2) |
|
Bone tumours: non-metastatic osteosarcoma |
|
|
410 | (2) |
|
Bone tumours: metastatic and recurrent osteosarcoma |
|
|
412 | (2) |
|
Bone tumours: Ewing's sarcoma |
|
|
414 | (4) |
|
Bone tumours: rare tumours |
|
|
418 | (2) |
|
Soft tissue sarcomas: introduction, clinical features, diagnosis, and staging |
|
|
420 | (4) |
|
Soft tissue sarcomas: management of localized disease |
|
|
424 | (2) |
|
Soft tissue sarcomas: management of locally advanced and metastatic disease |
|
|
426 | (2) |
|
Soft tissue sarcomas: special situations issues and future directions |
|
|
428 | (2) |
|
Gastrointestinal stromal tumour |
|
|
430 | (2) |
|
Future directions in soft tissue sarcoma |
|
|
432 | (2) |
|
Haematological malignancies |
|
|
|
Hodgkin disease: introduction |
|
|
434 | (2) |
|
Hodgkin disease: clinical features, diagnosis, and staging |
|
|
436 | (4) |
|
Hodgkin disease: treatment of early stage disease |
|
|
440 | (2) |
|
Hodgkin disease: treatment of advanced disease |
|
|
442 | (2) |
|
Hodgkin disease: management of recurrence |
|
|
444 | (2) |
|
Hodgkin disease: long-term toxicities and fertility issues |
|
|
446 | (2) |
|
Non-Hodgkin lymphoma: introduction and pathology |
|
|
448 | (4) |
|
Non-Hodgkin lymphoma: clinical features, diagnosis, staging, and prognosis |
|
|
452 | (2) |
|
Non-Hodgkin lymphoma: treatment of low-grade disease |
|
|
454 | (2) |
|
Non-Hodgkin lymphoma: mantle cell lymphoma |
|
|
456 | (2) |
|
Non-Hodgkin lymphoma: the role of stem cell transplantation in aggressive disease |
|
|
458 | (2) |
|
Cutaneous Non-Hodgkin lymphomas |
|
|
460 | (2) |
|
Non-Hodgkin lymphoma: extranodal involvement |
|
|
462 | (2) |
|
Non-Hodgkin lympthoma: targeted therapy |
|
|
464 | (2) |
|
Adult acute lymphoblastic leukaemia |
|
|
466 | (4) |
|
Adult acute myeloid leukaemia |
|
|
470 | (4) |
|
Chronic myeloid leukaemia: introduction |
|
|
474 | (2) |
|
Chronic myeloid leukaemia: staging, prognosis, and treatment |
|
|
476 | (3) |
|
Chronic lymphocytic leukaemia: introduction |
|
|
479 | (1) |
|
Chronic lymphocytic leukaemia: clinical features and staging |
|
|
480 | (2) |
|
Chronic lymphocytic leukaemia: treatment |
|
|
482 | (4) |
|
|
|
486 | (2) |
|
Myelodysplastic syndrome: introduction |
|
|
488 | (4) |
|
Myelodysplastic syndrome: clinical features, staging, and prognosis |
|
|
492 | (2) |
|
Myelodysplastic syndrome: treatment |
|
|
494 | (6) |
|
|
|
500 | (4) |
|
Multiple myeloma: staging, prognosis, and treatment response criteria |
|
|
504 | (2) |
|
Multiple myeloma: treatment |
|
|
506 | (5) |
|
|
|
511 | (1) |
|
Monoclonal gammopathy of undetermined significance |
|
|
512 | (2) |
|
|
|
514 | (1) |
|
Waldenstrom's macroglobulinemia |
|
|
515 | (3) |
|
|
|
518 | (2) |
|
|
|
520 | (1) |
|
|
|
521 | (1) |
|
|
|
522 | (2) |
|
|
|
|
Thyroid cancer: introduction |
|
|
524 | (2) |
|
Thyroid cancer: management of differentiated cancer |
|
|
526 | (4) |
|
Thyroid cancer: medullary carcinoma |
|
|
530 | (2) |
|
Thyroid cancer: anaplastic carcinoma |
|
|
532 | (1) |
|
|
|
533 | (1) |
|
|
|
534 | (2) |
|
|
|
536 | (2) |
|
|
|
538 | (2) |
|
|
|
|
|
|
540 | (4) |
|
|
|
544 | (2) |
|
Paediatric central nervous system tumours |
|
|
546 | (6) |
|
Paediatric solid tumours and kidney tumours |
|
|
552 | (2) |
|
|
|
554 | (1) |
|
|
|
555 | (1) |
|
Other paediatric tumours and Langerhans cell histiocytosis |
|
|
556 | (2) |
|
|
|
|
|
|
558 | (2) |
|
Non-AIDS defining cancers |
|
|
560 | (4) |
|
Cancers of unknown primary |
|
|
|
Cancer of unknown primary site |
|
|
564 | (3) |
|
5 Oncological emergencies |
|
|
567 | (34) |
|
|
|
568 | (1) |
|
|
|
569 | (1) |
|
|
|
570 | (1) |
|
|
|
571 | (1) |
|
|
|
572 | (1) |
|
|
|
573 | (1) |
|
|
|
574 | (4) |
|
|
|
578 | (2) |
|
Catheter associated infections |
|
|
580 | (2) |
|
Raised intracranial tension |
|
|
582 | (2) |
|
|
|
584 | (1) |
|
Cardiac arrest: introduction |
|
|
585 | (1) |
|
|
|
586 | (2) |
|
Venous thromboembolism (deep venous thrombosis and pulmonary embolism) |
|
|
588 | (3) |
|
Stridor and airway obstruction |
|
|
591 | (1) |
|
Superior vena caval obstruction |
|
|
592 | (1) |
|
|
|
593 | (1) |
|
Gastrointestinal bleeding |
|
|
594 | (1) |
|
|
|
595 | (1) |
|
|
|
596 | (1) |
|
Urinary tract obstruction |
|
|
597 | (1) |
|
Impending and pathological fractures |
|
|
598 | (3) |
|
6 Special situations in oncology |
|
|
601 | (38) |
|
|
|
602 | (2) |
|
|
|
604 | (4) |
|
|
|
608 | (2) |
|
|
|
610 | (4) |
|
|
|
614 | (2) |
|
|
|
616 | (2) |
|
|
|
618 | (2) |
|
|
|
620 | (4) |
|
Lifestyle choices after cancer |
|
|
624 | (4) |
|
The internet and oncology |
|
|
628 | (2) |
|
Negligence and risk management in oncology |
|
|
630 | (4) |
|
|
|
634 | (2) |
|
Supportive care during chemotherapy |
|
|
636 | (3) |
|
|
|
639 | (30) |
|
|
|
640 | (6) |
|
|
|
646 | (3) |
|
Malignant bowel obstruction |
|
|
649 | (1) |
|
|
|
650 | (1) |
|
|
|
651 | (1) |
|
|
|
652 | (2) |
|
|
|
654 | (2) |
|
|
|
656 | (1) |
|
|
|
657 | (1) |
|
|
|
658 | (1) |
|
|
|
659 | (1) |
|
|
|
660 | (1) |
|
|
|
661 | (1) |
|
|
|
662 | (1) |
|
|
|
663 | (1) |
|
|
|
664 | (5) |
|
8 Clinical management of cancer: flowcharts |
|
|
669 | (22) |
|
|
|
670 | (1) |
|
|
|
671 | (1) |
|
|
|
672 | (1) |
|
|
|
673 | (1) |
|
|
|
674 | (1) |
|
Epithelial ovarian cancer |
|
|
675 | (1) |
|
|
|
676 | (1) |
|
|
|
677 | (1) |
|
Non-small cell lung cancer |
|
|
678 | (1) |
|
|
|
679 | (1) |
|
|
|
680 | (1) |
|
|
|
681 | (1) |
|
|
|
682 | (1) |
|
|
|
683 | (1) |
|
Testicular cancer: seminoma |
|
|
684 | (1) |
|
Testicular cancer: non-seminoma |
|
|
685 | (1) |
|
|
|
686 | (1) |
|
|
|
687 | (1) |
|
|
|
688 | (1) |
|
|
|
689 | (2) |
|
|
|
691 | (14) |
|
Systemic therapy regimens |
|
|
692 | (3) |
|
Radiotherapy fractionation |
|
|
695 | (6) |
|
Glomerular filtration rate |
|
|
701 | (1) |
|
|
|
702 | (3) |
| Index |
|
705 | |
